Exelixis, Inc. (EXEL) Posts Q1 EPS Loss of $0.24
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $50.61 +0.46%
Financial Fact:
Loss from operations: -25.14M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Loss from operations: -25.14M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Exelixis, Inc. (NASDAQ: EXEL) reported Q1 EPS of ($0.24), $0.04 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $35.9 million versus the consensus estimate of $37.39 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
